1. 1356PThe level of circulating NKp46+ CD56dim CD16+ natural killer cells predicts distinct survival in non-small cell lung cancer. (23rd October 2018) Authors: Picard, E; Godet, Y; Laheurte, C; Boullerot, L; Lauret Marie Joseph, E; Jacquin, M; Kaulek, V; Eberst, G; Gaugler, B; Jacoulet, P; Gainet-Brun, M; Lahoucarde, J; Almotlak, H; Le Pimpec-Barthes, F; Fabre-Guillevin, E; Borg, C; Westeel, V; Adotevi, O Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 1435PBevacizumab as first-line treatment in advanced non-squamous non-small cell lung cancer (NSCLC) in patients aged over 65 years in France: Final results of the AVANTAGE study. (23rd October 2018) Authors: Lionel, F; Perol, D; Souquet, P-J; Le Caer, H; Dansin, E; Audigier Valette, C; Mouysset, J-L; Uffredi, M L; Ionescu-Goga, M; Veerabudun, K; Lelarge, Y; Fabre-Guillevin, E Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗